Literature DB >> 8140699

Topical fibronectin therapy of persistent corneal epithelial defects. Fibronectin Study Group.

J P McCulley1, B Horowitz, Z M Husseini, M Horowitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8140699      PMCID： PMC1298476     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN： 0065-9533


× No keyword cloud information.
  22 in total

1.  Cell surface protein partially restores morphology, adhesiveness, and contact inhibition of movement to transformed fibroblasts.

Authors:  K M Yamada; S S Yamada; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

2.  Modulation of the shape of epithelial lens cells in vitro directed by a retinal extract factor. A model of interconversions and the role of actin filaments and fibronectin.

Authors:  Y Courtois; C Arruti; D Barritault; J Tassin; M Olivié; R C Hughes
Journal:  Differentiation       Date:  1981       Impact factor: 3.880

3.  Fibronectin in healing rabbit corneal wounds.

Authors:  L S Fujikawa; C S Foster; T J Harrist; J M Lanigan; R B Colvin
Journal:  Lab Invest       Date:  1981-08       Impact factor: 5.662

4.  Fibroblast adhesion to fibrinogen and fibrin substrata: requirement for cold-insoluble globulin (plasma fibronectin).

Authors:  F Grinnell; M Feld; D Minter
Journal:  Cell       Date:  1980-02       Impact factor: 41.582

5.  Fibronectin in corneal wound healing: appearance in cultured rabbit cornea.

Authors:  T Nishida; S Nakagawa; Y Ohashi; T Awata; R Manabe
Journal:  Jpn J Ophthalmol       Date:  1982       Impact factor: 2.447

6.  Effects of LETS glycoprotein on cell motility.

Authors:  I U Ali; R O Hynes
Journal:  Cell       Date:  1978-06       Impact factor: 41.582

7.  Distribution of fibronectin during wound healing in vivo.

Authors:  F Grinnell; R E Billingham; L Burgess
Journal:  J Invest Dermatol       Date:  1981-03       Impact factor: 8.551

8.  Fibronectin. A new therapy for corneal trophic ulcer.

Authors:  T Nishida; Y Ohashi; T Awata; R Manabe
Journal:  Arch Ophthalmol       Date:  1983-07

9.  Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group.

Authors:  J D Nelson; J F Gordon
Journal:  Am J Ophthalmol       Date:  1992-10-15       Impact factor: 5.258
View more
  10 in total

1.  Amniotic membrane transplantation for severe neurotrophic corneal ulcers.

Authors:  H J Chen; R T Pires; S C Tseng
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

Review 2.  Novel Therapy to Treat Corneal Epithelial Defects: A Hypothesis with Growth Hormone.

Authors:  Barbara Wirostko; MaryJane Rafii; David A Sullivan; Julia Morelli; Juan Ding
Journal:  Ocul Surf       Date:  2015-03-28       Impact factor: 5.033

Review 3.  The role of fibronectin in corneal wound healing explored by a physician-scientist.

Authors:  Teruo Nishida
Journal:  Jpn J Ophthalmol       Date:  2012-07-27       Impact factor: 2.447

4.  Management strategies for persistent epithelial defects of the cornea.

Authors:  Lee R Katzman; Bennie H Jeng
Journal:  Saudi J Ophthalmol       Date:  2014-07-02

Review 5.  Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build.

Authors:  Josephine M J Stoffels; Chao Zhao; Wia Baron
Journal:  Cell Mol Life Sci       Date:  2013-06-12       Impact factor: 9.261

6.  Unusual Course of Crystalline Keratopathy in a Patient with Graft-Versus-Host Disease.

Authors:  Başak Bostancı; Yonca Aydın Akova
Journal:  Turk J Ophthalmol       Date:  2017-12-25

7.  The utilization of an ocular wound chamber on corneal epithelial wounds.

Authors:  Jennifer S McDaniel; Andrew W Holt; Elaine D Por; Elof Eriksson; Anthony J Johnson; Gina L Griffith
Journal:  Clin Ophthalmol       Date:  2018-05-14

Review 8.  Persistent Corneal Epithelial Defects: A Review Article.

Authors:  Uma Vaidyanathan; Grant C Hopping; Harry Y Liu; Anisha N Somani; Yasmyne C Ronquillo; Phillip C Hoopes; Majid Moshirfar
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2019

9.  Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects.

Authors:  Bennie H Jeng; Pedram Hamrah; Ziv Z Kirshner; Benjamin C Mendez; Howard C Wessel; Larry R Brown; David L Steed
Journal:  Transl Vis Sci Technol       Date:  2022-01-03       Impact factor: 3.283

10.  Cellular therapy of corneal epithelial defect by adipose mesenchymal stem cell-derived epithelial progenitors.

Authors:  Francisco Bandeira; Tze-Wei Goh; Melina Setiawan; Gary Hin-Fai Yam; Jodhbir S Mehta
Journal:  Stem Cell Res Ther       Date:  2020-01-03       Impact factor: 6.832
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.